Valeant Pharmaceuticals International Market and Forecasts, May 2013

You might be interested in: drug delivery, atopic dermatitis, dermatology, more »


 

» Download Public Reports

1-11 of 15 reports for Valeant Pharmaceuticals I...
Skin Care in Australia

Skin Care in Australia

  • Industry report
  • May 2012
  • 3 pages

The Skin Care in Australia Sector Capsule is a briefing which provides headlines, market trends, company shares, forecasting, competitive analysis and brand information, for t...

The European Equity Market Industry Brief

The European Equity Market Industry Brief

  • Industry report
  • May 2011
  • 15 pages

... A net standalone gain of 59.3M by selling the business to canada-based valeant pharmaceuticals international after an eight year buy and build campaign. Ab invalda benefitted from holding ...

Equity Market in Europe

Equity Market in Europe

  • Industry report
  • May 2011
  • 15 pages

... A net standalone gain of 59.3M by selling the business to canada-based valeant pharmaceuticals international after an eight year buy and build campaign. Ab invalda benefitted from holding ...

U.S. Food Industry : Production and Trade Statistics

U.S. Food Industry : Production and Trade Statistics

  • Industry report
  • February 2012
  • 4 pages

... Around the world valeant acquires brazilian food supplement company for $86m valeant pharmaceuticals international has acquired probiotica laboratorios, a brazilian sports nutrition and food supplement ...

The Indian Metal and Mineral Industry Brief

The Indian Metal and Mineral Industry Brief

  • Industry report
  • March 2012
  • 3 pages

... Coke oven, balance of plant for steel melt shop, hot strip mill, utilities and constructionworks for other areas. valeant pharmaceuticals international, inc. Announced yesterday that valeant has signed ...

Investment Banking Sector in Canada

Investment Banking Sector in Canada

  • Industry report
  • April 2012
  • 12 pages
  • by Corporation

... In the long run, will ensure china S prosperity. Deal making in growth markets did not come to a complete standstill. Two notable canadian-led buys included: valeant pharmaceuticals international announced ...

Drug and Medication Market Brief

Drug and Medication Market Brief

  • Industry report
  • May 2011
  • 10 pages
  • by Corporation

... In us promius pharma, an affiliate of dr reddy S laboratories, and valeant pharmaceuticals international signed a collaboration agreement for cloderm (clocortolone pivalate 0.1%) Cream. Under ...

Chemical and Material Sector  in The United States, Canada and China

Chemical and Material Sector in The United States, Canada and China

  • Industry report
  • March 2012
  • 8 pages

... Profit slipped to a first-quarter loss of $33.3 Million, due to a tax reassessment. valeant pharmaceuticals international (vrx) said it is expanding its presence in eastern europe by acquiring austrian ...

Pharmaceutical in Poland : Market Overview and Key Players

Pharmaceutical in Poland : Market Overview and Key Players

  • Industry report
  • June 2011
  • 17 pages

... Poland) 30.75 85.00 1 February 2011 pharmaswiss valeant pharmaceuticals international company managers ; hbm bioventures ; polish enterprise fund vi 350.00 100.00 14 January 2011 chemiks atlas ...

Drug Delivery Technology Industry Brief

Drug Delivery Technology Industry Brief

  • Industry report
  • September 2012
  • 24 pages

... Are registered trademarks of basf se. Osdrc is a registered trademark of sanwa kagaku kenkyusho co, ltd. Zelapar is a registered trademarks of valeant pharmaceuticals international, inc. Eldepryl ...

The Indian Tourism and Leisure Business : Production and Trade Statistics

The Indian Tourism and Leisure Business : Production and Trade Statistics

  • Industry report
  • April 2012
  • 16 pages
  • by Market Research Publisher

... Canada-based valeant pharmaceuticals international inc agreed to buy russian pharma company natur produkt international, jsc for about us$ 180 million to tap into the otc market in the country. Budget impact analysis ...

» Purchase Premium Reports (From $ 99 - $ 5 450)

67 reports for Valeant Pharmaceuticals I...
Dermatomycoses Global Clinical Trials Review, H1, 2013

Dermatomycoses Global Clinical Trials Review, H1, 2013

  • $ 2 500
  • Industry report
  • March 2013
  • by Global Data

Dermatomycoses Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Dermatomycoses Global Clinical Trials Review, H1, 2013" provides data on the Dermatomycoses clinical ...


Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.